معرفی
David Balgoma is a Researcher at Uppsala University's Department of Medicinal Chemistry; Analytical Pharmaceutical Chemistry, specializing in lipidomics and metabolomics with advanced analytical chemistry methodology development. His work integrates mass spectrometry, chromatography, and computational approaches to address biomedical challenges.
His research focuses on:
- Lipid metabolism alterations in liver cancer and response to chemotherapeutics (e.g., doxorubicin)
- Development of novel analytical techniques for lipid separation and characterization
- Role of lipids in viral infections and deep-sea organism physiology
- Engineering ROS-sensitive biomaterials for wound healing applications
Analysis of his 2022-2024 publications reveals consistent innovation in analytical methodology (chromatographic optimization, peak characterization algorithms) coupled with biological insights into lipid pathways in disease. His interdisciplinary approach bridges analytical chemistry, oncology, and biomaterials science, frequently appearing in high-impact journals like Analytica Chimica Acta and Molecular Metabolism.
